Sanofi ' s Biosimilar Insulin Aspart Gets Green Light in EU Sanofi ' s Biosimilar Insulin Aspart Gets Green Light in EU

Biosimilar of fast-acting mealtime insulin aspart is given positive opinion by CHMP.International Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news